TRUEX PAUL F 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 28, 2021
Insider Transaction Report
Form 4
TRUEX PAUL F
Director
Transactions
- Award
Stock Option (right to buy)
2021-01-26+32,000→ 32,000 totalExercise: $5.78Exp: 2031-01-25→ Common Stock (32,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2021.